Fed Greenlights PEDv Vaccine
There may now be light at the end of the porcine epidemic diarrhea virus (PEDv) tunnel that's rocked the U.S. hog industry in the last year.
On Monday, officials with the USDA Animal and Plant Health Inspection Service (APHIS) announced they've granted a license to an Ames, Iowa-based company for a vaccine that "may aid in the control of PEDv in swine," according to a USDA report. The license issued to Harrisvaccines, Inc., is conditional, meaning it has been issued "based on full safety, purity testing, and an expectation of efficicay." It will be administered to sows so that they may build antibodies and pass them along to piglets, the ultimate benefactors of the vaccine.
"Preliminary studies have been promising, and they’ve shown sufficient data that we think the vaccine will be effective," according to a USDA report. "The company will continue working toward completing the requirements for a full license. In the meantime, there are no restrictions on vaccine use under the conditional license."
The drug's licensing comes as part of a $26.2 million effort by APHIS to combat PEDv through the development of vaccines and general disease reporting. The vaccine is just part of an overall plan the federal government has undertaken to stem the disease that's killed hundreds of thousands of hogs in the U.S. in the last year.
"Plans will be based on industry-recommended best practices, and include disease monitoring through testing and biosecurity measures," according to an APHIS report. "These steps will help to reduce virus shed in affected animals, prevent further spread of the disease, and enable continued movement of animals for production and processing."